BioSpace News Archive

FDA

CORRECTING and REPLACING Vertex Announces U.S. FDA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations

Vertex Pharmaceuticals Incorporated announced the U.S. Food and Drug Administration approved expanded use of TRIKAFTA® to include children with cystic fibrosis ages 6 through 11 years who have at least one F508del mutation in the cystic fibrosis transmembrane conductance regulator gene or a mutation in the CFTR gene that is responsive to TRIKAFTA based on in vitro data.

June 9, 2021
·
10 min read
Smart Syringes Market Technological Developments in The Field of Smart Syringes

The market is estimated to grow with a CAGR of 10.6% from 2019-2027.

June 9, 2021
·
5 min read
Drug Development

PainQx Awarded $1.5M Phase II SBIR Contract from the Defense Health Agency SBIR Program to Refine Objective Pain Assessment Technology

PainQx, Inc. (www.painqx.com), is pleased to announce it has been awarded a Defense Health Agency (www.health.mil) Phase II SBIR contract.

June 9, 2021
·
2 min read
InMed Pharmaceuticals to Present at the 2021 BIO Digital Conference

InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), today announced that Eric. A. Adams, President and CEO of InMed, will present at 2021 BIO Digital, the premier biotech conference.

June 9, 2021
·
2 min read
New next generation device improves the well-being of people affected by swallowing disorders and dysphagia

The Mobili-T® system was brought to market by a health company, True Angle, an award-winning startup that just raised an oversubscribed $1.64M investment round backed by investment firms such as Accelerate Fund, Thin Air Labs, The 51 and others.

June 9, 2021
·
2 min read
BioMidwest

Thomas Jefferson University Hospitals and Mentice to establish a Simulation Center of Excellence for Interventional Radiology

Thomas Jefferson University Hospitals and Mentice have formed a strategic collaboration to establish a Simulation Center of Excellence uniting Jefferson’s world-class interventional radiology team with Mentice’s virtual patient technology aiming to elevate clinical training and to introduce advanced Virtual Reality simulation solutions for physicians in clinical practice.

June 9, 2021
·
3 min read
DKT WomanCare and Shanghai Dahua Pharmaceutical Reduce Price of Levoplant™ to $6.70, Increasing Affordability for FP2020 Countries, Despite Widespread Challenges Due to Covid-19

Despite global disruptions to family planning services due to the Covid-19 pandemic, WomanCare Global Trading CIC and Shanghai Dahua Pharmaceutical Co., Ltd. are proud to announce a price reduction of Levoplant, a two-rod contraceptive implant prequalified by the World Health Organization for up to three years of use.

June 9, 2021
·
4 min read
Business

Health and Human Services Expert Mary L. Smith Joins PTC Therapeutics’ Board of Directors

Ms. Smith has previously served as the Principal Deputy Director and CEO equivalent at the Indian Health Service, a $6 billion division of the U.S. Department of Health and Human Services and system of hospitals providing healthcare to more than two million Native Americans in the United States.

June 9, 2021
·
4 min read
Genetown

Gamida Cell to Present Corporate Highlights at Multiple Investor Conferences in June

Gamida Cell Ltd. today announced that company management will present its corporate highlights at the following investor conferences in June.

June 9, 2021
·
2 min read
FDA

Vertex Announces U.S. FDA Approval for TRIKAFTA® (elexacaftor/tezacaftor/ivacaftor and ivacaftor) in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations

Vertex Announces U.S. FDA Approval for TRIKAFTA ® in Children With Cystic Fibrosis Ages 6 through 11 With Certain Mutations.

June 9, 2021
·
9 min read